Skip to main content
. 2013 Jan 18;18(2):221–231. doi: 10.1634/theoncologist.2012-0226

Table 1.

Incidence of cardiotoxicity in HER2-directed and angiogenesis inhibitor clinical trials

graphic file with name onc00213-1190-t01.jpg

Abbreviations: CRC, colorectal cancer; GIST, gastrointestinal stromal tumor; HF, heart failure; mAb, monoclonal antibody; MBC, metastatic breast cancer; MGC, metastatic gastric cancer; mHRPC, metastatic hormone-refractory prostate cancer; MTC, metastatic medullary thyroid cancer, NA, not available; NSCLC, non-small-cell lung cancer; RCC, renal cell carcinoma; TKI, tyrosine kinase inhibitor.